Bachem signs follow-on contract
Submitted by:
Andrew Warmington
Bachem has signed a further work order with an unnamed customer for large volumes of
Bachem acquires third Swiss site
Submitted by:
Andrew Warmington
Peptides giant Bachem has agreed to acquire an undeveloped site covering 155,000 m2 in
Olon presents biotech plan
Submitted by:
Andrew Warmington
Italian CDMO and API supplier Olon has presented a two-year, €30 million plan to expand
Singapore site for WuXi AppTec
Submitted by:
Andrew Warmington
WuXi AppTec has announced a plan to build a new R&D and manufacturing site in
CordenPharma for sale, reports claim
Submitted by:
Andrew Warmington
According to the German business newspaper Handelsblatt, the International Chemical Investors Group (ICIG) intends to
Multi-track investment for CordenPharma
Submitted by:
Andrew Warmington
CDMO CordenPharma is planning to invest heavily in all its platforms in terms of both
Greening SPPS with Bachem
Submitted by:
Andrew Warmington
Bachem, the world’s largest peptides manufacturer, has announced some results of two studies it carried
CordenPharma further expands peptides
Submitted by:
Andrew Warmington
CordenPharma is to expand non-GMP solid-phase peptide synthesis (SPPS) capacity at its centre of excellence
Bachem in Molecular Hiving deal
Submitted by:
Andrew Warmington
Bachem, the world’s largest producer of pharmaceutical peptides and ologonucleotides, has signed an exclusive licensing